Biotechnology Stocks I: Returns for Rhythm Pharmaceuticals, Inc. (RYTM)
RYTM has no dividends.
Table and Chart of RYTM Performance
See what a $1,000 investment in RYTM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RYTM Returns | |
|---|---|
| Start Date | Nov-30-2017 |
| Start Price | $28.58 |
| End Date | Jan-17-2025 |
| End Price | $54.54 |
| # Prices | 87 |
| Min Date | May-31-2022 |
| Min Price | $3.44 |
| Max Date | Nov-29-2024 |
| Max Price | $62.04 |
| Total Return | 90.83% |
| Annualized Return | 9.32% |
| Current Value of $1,000 Purchase | $1,908 |
| Number Returns | 3,741 |
| Average Return | 46.56% |
| Number Profitable Returns | 1,969 |
| Percent Profitable Returns | 52.63% |
| Number Unprofitable Returns | 1,772 |
| Percent Unprofitable Returns | 47.37% |
| Profitable to Unprofitable Returns Ratio | 1.11 |
| RYTM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,351,870,000 |
| Beta | 2.093 | Price to Sales | 29.79 |
| Earnings per Share | $-4.3200 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 298.87 |
| PRICE DATA | |
| 52 Week High | $68.58 |
| 52 Week Low | $35.17 |
| Analyst Target Price | $73.18 |
| 50-Day Moving Average | $58.36 |
| 200-Day Moving Average | $48.29 |
| FINANCIAL DATA | |
| Revenue per Share | $1.863 |
| Revenue | $112,530,000 |
| Profit Margin | -230.1% |
| Return on Equity | -147.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RYTM Compare Returns with S&P 500
RYTM Trendline Chart
RYTM Moving Average Chart
RYTM Stock Return Map - See Patterns of Gains and Losses
RYTM Stock Returns/Purchase Dates